ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

American Academy of Neurology 

1080 Montreal Avenue

St. Paul  Minnesota  55116  U.S.A.
Phone: 651-695-1940 Fax: 651-695-2791


SEARCH JOBS








 Company News
BioMarin (BMRN) Presents Data On Duchenne Muscular Dystrophy At The 67th American Academy of Neurology Annual Meeting 4/23/2015 7:07:56 PM
Baseline Characteristics Of 228 Subjects Enrolled In MediciNova, Inc.'s Phase IIb Trial Of MN-166 (Ibudilast) In Progressive MS Presented At The American Academy of Neurology 67th Annual Meeting 4/23/2015 7:06:45 PM
Teva (TEVA) Presents Data Comparing Early Treatment With COPAXONE 40 Mg/Ml To Delayed Start Treatment At 67th American Academy of Neurology Annual Meeting In Washington, D.C. 4/23/2015 8:39:25 AM
Acorda Therapeutics (ACOR) Presents Data On First Clinical Study Of Remyelinating Antibody For Multiple Sclerosis At American Academy of Neurology Annual Meeting 4/22/2015 10:57:10 AM
Flex Pharma (FLKS) Data Presented At American Academy of Neurology Platform Session 4/21/2015 3:36:11 PM
Important UCB, Inc. (UCBJF.PK) Presence At The 2015 American Academy of Neurology Meeting 4/21/2015 1:20:16 PM
Upsher-Smith Laboratories Research On Qudexy XR (topiramate) Extended-Release Capsules Highlighted At the 2015 American Academy of Neurology Annual Meeting 4/21/2015 11:34:31 AM
Biogen (BIIB) Release: PLEGRIDY┬« (Peginterferon Beta-1a) Three-Year Data Presented At American Academy of Neurology Annual Meeting Support Long-Term Safety And Efficacy In Multiple Sclerosis Patients 4/21/2015 11:32:59 AM
Opexa Therapeutics (OPXA) Invited To Present Biomarker Data From NMO Patients At The American Academy of Neurology 2015 Annual Meeting 4/20/2015 10:56:46 AM
PTC Therapeutics (PTCT) Phase 1 Data From Spinal Muscular Atrophy Program To Be Presented At The 2015 American Academy of Neurology Annual Meeting 4/20/2015 10:52:08 AM
12345678910...